Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients
Gilberto Marcelo Sperandio da Silva1* 
Mauro Felippe Felix Mediano1 Michele Ferreira Murgel1 Patricia Mello Andrade1 Marcelo Teixeira de Holanda1 Andréa Rodrigues da Costa1 Henrique Horta Veloso1 Fernanda Martins Carneiro1 Cláudia Maria Valete Rosalino1 Andréa Silvestre de Sousa1 Fernanda de Souza Nogueira Sardinha Mendes1 Roberta Olmo Pinheiro2 Valdiléa Gonçalves Veloso1 Roberto Magalhães Saraiva1,3 Alejandro Marcel Hasslocher-Moreno1,3- 1Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil
- 2Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil
- 3Ibero-American Network for Chagas Disease, Barcelona, Spain
A corrigendum on
Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients
by Sperandio da Silva, G. M., Mediano, M. F. F., Murgel, M. F., Andrade, P. M., Holanda, M. T. d., da Costa, A. R., Veloso, H. H., Carneiro, F. M., Valete Rosalino, C. M., de Sousa, A. S., Mendes F. d. S. N. S., Pinheiro, R. O., Veloso, V. G., Saraiva, R. M., and Hasslocher-Moreno, A. M. (2022). Front. Med. 9:880796. doi: 10.3389/fmed.2022.880796
Addition of an Author
In the published article, there was an error in the author list, and authors Andréa Rodrigues da Costa, Henrique Horta Veloso, and Fernanda Martins Carneiro were erroneously excluded. The corrected author list appears below.
Gilberto Marcelo Sperandio da Silva1*, Mauro Felippe Felix Mediano1, Michele Ferreira Murgel1, Patricia Mello Andrade1, Marcelo Teixeira de Holanda1, Andréa Rodrigues da Costa1, Henrique Horta Veloso1, Fernanda Martins Carneiro1, Cláudia Maria Valete Rosalino1, Andréa Silvestre de Sousa1, Fernanda de Souza Nogueira Sardinha Mendes1, Roberta Olmo Pinheiro2, Valdiléa Gonçalves Veloso1, Roberto Magalhães Saraiva1, 3 and Alejandro Marcel Hasslocher-Moreno1, 3
The corrected Author Contributions Statement appears below.
AH-M, MMu, MMe, AC, FC, and PA collected, interpreted data, and prepared tables. GS, AH-M, RS, and MMe analyzed the data. MMe, MMu, PA, MH, AC, HV, FC, CV, AS, FM, RP, VV, RS, and AH-M reviewed and edited the manuscript. GS, MH, CV, AS, FM, RP, VV, AC, HV, FC, MMe, RS, and AH-M conceptualized, designed study, supervised the study, and interpreted data. GS wrote the manuscript. All authors contributed to the article and approved the submitted version.
The authors apologize for this inclusion and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Chagas disease, SARS-CoV-2, COVID-19, in-hospital mortality, Trypanosoma cruzi
Citation: Sperandio da Silva GM, Mediano MFF, Murgel MF, Andrade PM, Holanda MTd, da Costa AR, Veloso HH, Carneiro FM, Valete Rosalino CM, de Sousa AS, Mendes FdSNS, Pinheiro RO, Veloso VG, Saraiva RM and Hasslocher-Moreno AM (2022) Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients. Front. Med. 9:963805. doi: 10.3389/fmed.2022.963805
Received: 09 June 2022; Accepted: 30 June 2022;
Published: 26 July 2022.
Copyright © 2022 Sperandio da Silva, Mediano, Murgel, Andrade, de Holanda, da Costa, Veloso, Carneiro, Valete Rosalino, de Sousa, Mendes, Pinheiro, Veloso, Saraiva and Hasslocher-Moreno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gilberto Marcelo Sperandio da Silva, gilbertomarcelo@gmail.com; gilberto.silva@ini.fiocruz.br